Multiple bacterial macromolecular targets

Multiple bacterial macromolecular targets is a pharmacological designation for a broad set of essential bacterial components—including DNA, RNA, ribosomal proteins, and metabolic enzymes—that are simultaneously disrupted by certain antimicrobial agents. This non-specific targeting is characteristic of the nitroimidazole and nitrofuran drug classes, which act as prodrugs activated within the bacterial cell by enzymes like nitroreductases or flavoproteins (DrugBank, DB00916; StatPearls, NBK470526). Upon activation, these drugs generate highly reactive intermediates, such as free radicals or electrophilic species, that induce widespread oxidative damage and form covalent adducts with various cellular macromolecules (PubMed, PMID: 15833283). This multi-pronged attack effectively halts DNA replication, transcription, and protein synthesis, leading to rapid bacterial cell death. Because these drugs hit multiple essential pathways at once, they are particularly effective against anaerobic bacteria and protozoa, and the emergence of resistance is often more complex than with single-target antibiotics (PubMed, PMID: 29439114). However, the term is considered a non-specific grouping rather than a single molecular target, reflecting a mechanism of action that involves global cellular damage.

Other names

Bacterial macromoleculesMultiple bacterial targetsNon-specific bacterial targetsBacterial DNA, RNA, and proteins

Reduction of the drug's nitro group by bacterial enzymes (e.g., nitroreductases) to form highly reactive thiols, nitronate radicals, or other electrophilic intermediates that cause oxidative damage and covalent binding to DNA, RNA, and proteins.